Sort
51,593 grants matching “hepatitis”
GENERAL CLINICAL RESEARCH CENTER
$1,976,557University Of Colorado Denver · M01 · FY2000 · RR
BIOENGINEERED ANTIBODIES IN CANCER IMAGING AND THERAPY
$1,976,521City Of Hope/Beckman Research Institute · P01 · FY2000 · CA
Mechanisms of cardiac ischemia-reperfusion injury and cardioprotection
$1,975,548Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
EXPANSION OF NIH CHIMPANZEE HOLDING FAC
$1,975,176University Of Louisiana At Lafayette · C06 · FY2002 · RR
CHIMPANZEE HOLDNG FAC EXPANSION: HEALTH &WELL BEING FOR CHIMPANZEE NERVOUS SYST
$1,975,176University Of Louisiana At Lafayette · C06 · FY2002 · RR
NIDA Clinical Trials Network: Greater New York Node
$1,974,434John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Sirtuins and nuclear receptors in aging and age-associated diseases
$1,974,079Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
A Novel ENaC Blocker/Osmolyte Inhalation Solution for the Treatment of Muco-Obstructive Lung Diseases
$1,971,749Karl H Donn · Parion Sciences, Inc. · R44 · FY2025 · HL
Integrated University of Puerto Rico Clinical Trials Unit
$1,969,960Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2017 · AI
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
$1,969,560Rebecca Gersnoviez Clifton · George Washington University · U24 · FY2021 · HL
Host-pathogen competition in IFN mediated antiviral defense
$1,969,262Jae U Jung · University Of Southern California · U19 · FY2009 · AI
Cell surface serine proteases in development, tissue repair, and malignancy
$1,967,547Thomas H Bugge · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE
Development of Novel Therapies for NIDDM
$1,966,913Christopher B Newgard · Duke University · P01 · FY2014 · DK
Development of Novel Therapies for NIDDM
$1,966,913Christopher B Newgard · Duke University · P01 · FY2016 · DK
Development of Novel Therapies for NIDDM
$1,966,913Christopher B Newgard · Duke University · P01 · FY2015 · DK
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$1,966,903Dana-Farber Cancer Institute · P01 · FY2003 · AI
improving outcomes after stem cell transplantation
$1,966,744Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$1,966,176Julie A. Ake · Walter Reed Army Institute Of Research · UM1 · FY2020 · AI
IMPROVED BLOOD SERVICE CARE FOR CYTOPENIC PATIENTS
$1,965,772Immune Disease Institute, Inc. · P01 · FY2003 · HL
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$1,965,696Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit
$1,965,634Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2015 · AI
CIP Microbiome and Genetics Core
$1,964,469Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Gene Therapy for Hemophilia
$1,963,829Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2013 · HL
Consultation and Collaboration
$1,963,669Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
ADULT AIDS CLINICAL TRIALS UNIT (AACTU)
$1,963,534University Of Rochester · U01 · FY2003 · AI